At Bukwang Pharmaceutical, we are dedicated to the continuous development and
production of world-class pharmaceuticals that bring better health to life.
As a well-established R&D-focused pharmaceutical company, we are now actively leveraging our position on the leading edge of open innovation to develop innovative drugs and expand our pipeline as we set our sights on becoming a global pharmaceutical innovator.view more
Medication prescribed for the treatment of schizophrenia and bipolar depression by blocking dopamine receptor in the brainview more
A novel drug formulation combining proven safe medications for the treatment of dyskinesia in Parkinson's diseaseview more
A metastatic prostate cancer treatment being developed by Dyna Therapeutics, a subsidiary specializing in formulation development for Bukwang Pharmaceuticalview more
Maximizing R&D efficiency and commercialization outcomes by combining external technology with internal R&D capabilitiesview more
Bukwang Pharmaceutical will continue on the path to a prosperous life and a healthy future for the next 100 years.
We pursue a variety of R&D open innovation strategies ranging from joint ventures and
research collaborations to mergers and acquisitions as we strive to expand our drug
pipeline and develop new business models.
Please check for new updates and various news